The TOE + CIS group showed partial restoration of NF-κB (−12%), IL-6 (−21%), MDA (−21%), TOS (−17%), and TAS (+28%) versus CIS (allp < 0.05), indicating reduction of oxidative and inflammatory damage. The gene discussed is IL6; the disease is in situ carcinoma.